The European Respiratory Review: mature, expanding and targeting new challenges Vincent Cottin Eur Respir Rev 2013; 22: 1-2 | |
Personalised medicine for cystic fibrosis: treating the basic defect J. Stuart Elborn Eur Respir Rev 2013; 22: 3-5 | |
Scleroderma lung disease Joshua J. Solomon, Amy L. Olson, Aryeh Fischer, Todd Bull, Kevin K. Brown, Ganesh Raghu Eur Respir Rev 2013; 22: 6-19 | |
Pulmonary hypertension Andrew Peacock Eur Respir Rev 2013; 22: 20-25 | |
Interstitial lung disease Vincent Cottin Eur Respir Rev 2013; 22: 26-32 | |
Nonsmall cell lung cancer Jean-Paul Sculier Eur Respir Rev 2013; 22: 33-36 | |
Smoking cessation and COPD Philip Tønnesen Eur Respir Rev 2013; 22: 37-43 | |
Adult-onset asthma: is it really different? Selma B. de Nijs, Lisette N. Venekamp, and Elisabeth H. Bel Eur Respir Rev 2013; 22: 44-52 | |
Stratified medicine: drugs meet genetics Ian P. Hall Eur Respir Rev 2013; 22: 53-57 | |
Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis Nico Derichs Eur Respir Rev 2013; 22: 58-65 | |
Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation Isabelle Sermet-Gaudelus Eur Respir Rev 2013; 22: 66-71 | |
The impact of personalised therapies on respiratory medicine J. Stuart Elborn Eur Respir Rev 2013; 22: 72-74 | |
Thymic epithelial tumours: from basic principles to individualised treatment strategies Nicolas Girard Eur Respir Rev 2013; 22: 75-87 | |
Hot tub lung: an occupational hazard Harald Fjällbrant, Magnus Akerstrom, Erik Svensson, Eva Andersson Eur Respir Rev 2013; 22: 88-90 | |
Solitary cystic mediastinal lymphangioma Nataliya Khobta, Pascale Tomasini, Delphine Trousse, Fabien Maldonado, Pascal Chanez, Philippe Astoul Eur Respir Rev 2013; 22: 91-93 | |
Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients Kamel Amraoui, Karim Belhadj, Bernard Maître, Caroline Jannière-Nartey, Jehan Dupuis Eur Respir Rev 2013; 22: 93-95 | |
What are the benefits of medical screening and surveillance? Jean-Luc Malo Eur Respir Rev 2013; 22: 96 | |
What are the benefits of medical screening and surveillance? Xaver Baur, Dennis Wilken, Jos Rooyackers, Dick Heederik Eur Respir Rev 2013; 22: 96-97 | |
Progressive metastatic pulmonary calcification after successful renal transplantation Kazuhiro Yatera, Toshinori Kawanami, Hiroshi Ishimoto, Hiroshi Mukae Eur Respir Rev 2013; 22: 98-99 | |
Book Review: Challenging cases in pulmonology J. Le Pavec Eur Respir Rev 2013; 22: 100 | |